AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Transportation TRA

Issues relating to requirements for ride hailing vehicles and companies, S. 1871, Samis Law. Issues relating to highway/transportation reauthorization and appropriations.

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Transportation, Dept of (DOT); Energy, Dept of; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); SENATE; Veterans Affairs, Dept of (VA); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA)

Bills named: S. 1871 (116th)

Taxation/Internal Revenue Code TAX

Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues respecting the medical expense deduction. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to the medical expense deduction and unrelated business income taxation (UBIT) in H.R. 1865, Further Consolidated Appropriations Act, 2020.

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; Centers For Disease Control & Prevention (CDC); Energy, Dept of; White House Office; Labor, Dept of (DOL); Defense, Dept of (DOD); Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Federal Trade Commission (FTC); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA)

Bills named: S. 1257 (116th), H.R. 1865 (116th), H.R. 3832 (116th)

Medicare/Medicaid MMM

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; S.2218 and H.R 4821, the Covering Our FAS Allies (COFA) Act & issues related to Medicaid coverage for Compacts of Free Association (COFA) migrants; CMS-issued regulations pertaining to Medicare Part B reimbursement - the CY2020 Medicare Physician Fee Schedule; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; Issues related to potential Administration guidance relating to giving states the option to block grant their Medicaid program; Issues related to Puerto Ricos Medicaid program, including H.R. 3631, Territories Health Care Improvement Act; H.R. 3, the Lower Drug Prices Now Act - legislation for lowering prescription drug costs, lowering out of pocket expenses for Medicare beneficiaries, and placing a cap on Medicare Part D; S. 2543, the Prescription Drug Pricing Reduction Act of 2019 - legislation for lowering prescription drug costs, lowering out of pocket costs for Medicare beneficiaries, and placing a cap on Medicare Part D; Issues related to Medicaid Non-Emergency Medical Transportation; and S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year.

Contacted: Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); White House Office; Centers For Disease Control & Prevention (CDC); SENATE; Environmental Protection Agency (EPA); Labor, Dept of (DOL); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Transportation, Dept of (DOT); Food & Drug Administration (FDA); Energy, Dept of; Veterans Affairs, Dept of (VA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Bills named: S. 2911 (116th), S. 2218 (116th), H.R. 913 (116th), S. 2543 (116th), S. 668 (116th), H.R. 1570 (116th), H.R. 3631 (116th), H.R. 4821 (116th), H.R. 6808 (116th), H.R. 1948 (116th), H.R. 3 (116th)

Budget/Appropriations BUD

FY 2020 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding for cervical cancer screening & treatment and HPV vaccination; and issues related to highway authorization and appropriations.

Contacted: Labor, Dept of (DOL); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; Transportation, Dept of (DOT); Veterans Affairs, Dept of (VA); U.S. Agency for International Development (USAID); State, Dept of (DOS); White House Office; SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA)

Tobacco TOB

Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; S. 655 and H.R.1498, Stopping Appealing Flavors in E-Cigarettes for Kids Act; S. 1048 and H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; H.R.1854 & S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 2084, the Stopping Consumption of Tobacco by Teens Act of 2019; H.R. 2339 and S. 3174, Reversing the Youth Tobacco Epidemic Act; S. 1258 and H.R. 2411, Tobacco to 21 Act, and H.R. 1865, the Further consolidated Appropriations Act, 2020; Issues related to FDA tobacco control to be considered in House and Senate in the FY20 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation; H.R. 293, Youth Vaping Prevention Act of 2019; S. 616, E-Cigarette youth Protection Act; S. 1253, Preventing Online Sales of E-Cigarettes to Children Act; S. 1541, Tobacco-Free Youth Act; S. 1895, Lower Health Care Costs Act regarding tobacco 21 age of sale provisions; H.R. 1865 Further Consolidated Appropriations Act, 2020 regarding tobacco 21 age of sale provisions; S 1832, Smoke-Free Schools Act; S. 2726, Banning Smoking on Amtrak Act of 2019; Issues related to smoke-free policies for the Veterans Health Administration, H.R. 3700 and S. 2106; H.R. 4249, Stop Vaping Ads Act; S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019; S. 2519, Ending New Nicotine Dependencies Act of 2019 (ENND Act); H.R. 4624 Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2019; H.R. 5482 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; S. 3096 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; H.R. 5482 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; H.R. 5005 the Preventing Vape Use Act; Issues related to taxation of tobacco products: S. 2463, E-cigarette Tax Parity Act; S. 2517, Tobacco Tax Equity Act of 2019, and H.R. 4742 a bill to amend the Internal Revenue Code of 1986 to impose a tax on nicotine used in e-cigarettes; and Issues related to FDAs development of its final guidance on Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization.

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); Transportation, Dept of (DOT); Energy, Dept of; SENATE; U.S. Agency for International Development (USAID); White House Office; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 5482 (116th), H.R. 2411 (116th), S. 2726 (116th), S. 1258 (116th), S. 2463 (116th), H.R. 4249 (116th), H.R. 2111 (116th), H.R. 1865 (116th), H.R. 4742 (116th), S. 1541 (116th), H.R. 293 (116th), S. 2517 (116th), H.R. 2084 (116th), H.R. 2339 (116th), S. 2550 (116th), S. 3096 (116th), S. 655 (116th), H.R. 4425 (116th), S. 2106 (116th), S. 1895 (116th), S. 616 (116th), H.R. 3700 (116th), S. 3174 (116th), S. 1253 (116th), H.R. 4624 (116th), S. 1048 (116th), H.R. 1498 (116th), H.R. 1854 (116th), H.R. 5005 (116th), S. 2519 (116th), S. 9 (116th)

Health Issues HCR

Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 HR___, Medical Records Fairness Act (Rep. Bill Foster, D-IL); S. 2497, the Dependent Income Exclusion Act; SJ Res 52, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; Issues related to prescription drug costs - H.R. 3, the Lower Prescription Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act of 2019; Issues related to HHS regulation of prescription drug prices; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; S. 2546 & H.R. 2279, the Safe Step Act of 2019 - amends the Employee Retirement Income Security Act (ERISA) to require group health plans to provide an exception process for any medication step therapy protocol, tools used by health plans to control spending on patients medications, to help ensure patients are able to safely and efficiently access treatment; S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; S. 1608, the Promoting Physical Activity for Americans Act; and Issues related to the nomination of Dr. Stephen Hahn to be Commissioner of the Food and Drug Administration.

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Transportation, Dept of (DOT); Energy, Dept of; Federal Trade Commission (FTC); Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); White House Office; U.S. Agency for International Development (USAID)

Bills named: S. 2543 (116th), H.R. 3 (116th), S.Res. 223 (116th), S. 1107 (116th), H.R. 3630 (116th), H.R. 1730 (116th), H.R. 2279 (116th), S. 2546 (116th), H.R. 2689 (116th), H.Res. 14 (116th), H.Res. 282 (116th), H.R. 1028 (116th), S. 2911 (116th), S.J.Res. 52 (116th), H.R. 2222 (116th), S. 2424 (116th), S. 1608 (116th), S. 2032 (116th), H.R. 647 (116th), H.R. 1409 (116th), S. 1438 (116th), H.R. 1966 (116th), S. 2358 (116th), S. 2497 (116th), S. 2080 (116th), H.R. 4439 (116th), H.R. 4078 (116th), H.R. 4897 (116th), S. 1719 (116th), S. 741 (116th)